EP1143948A3 - Antagoniste des glucocorticoides, specifique du foie, pour le traitement du diabete - Google Patents

Antagoniste des glucocorticoides, specifique du foie, pour le traitement du diabete

Info

Publication number
EP1143948A3
EP1143948A3 EP99925232A EP99925232A EP1143948A3 EP 1143948 A3 EP1143948 A3 EP 1143948A3 EP 99925232 A EP99925232 A EP 99925232A EP 99925232 A EP99925232 A EP 99925232A EP 1143948 A3 EP1143948 A3 EP 1143948A3
Authority
EP
European Patent Office
Prior art keywords
liver
treating diabetes
selective glucocorticoid
glucocorticoid antagonist
antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99925232A
Other languages
German (de)
English (en)
Other versions
EP1143948A2 (fr
Inventor
Theresa Apelqvist
Suad Efendic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Karo Pharma AB
Original Assignee
Karo Bio AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9812314.4A external-priority patent/GB9812314D0/en
Priority claimed from GBGB9815149.1A external-priority patent/GB9815149D0/en
Application filed by Karo Bio AB filed Critical Karo Bio AB
Publication of EP1143948A2 publication Critical patent/EP1143948A2/fr
Publication of EP1143948A3 publication Critical patent/EP1143948A3/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP99925232A 1998-06-08 1999-06-07 Antagoniste des glucocorticoides, specifique du foie, pour le traitement du diabete Withdrawn EP1143948A3 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9812314.4A GB9812314D0 (en) 1998-06-08 1998-06-08 Treatment of diabetes
GB9812314 1998-06-08
GB9815149 1998-07-13
GBGB9815149.1A GB9815149D0 (en) 1998-07-13 1998-07-13 Treatment of diabetes
PCT/IB1999/001175 WO1999063976A2 (fr) 1998-06-08 1999-06-07 Traitement de diabetes

Publications (2)

Publication Number Publication Date
EP1143948A2 EP1143948A2 (fr) 2001-10-17
EP1143948A3 true EP1143948A3 (fr) 2002-09-11

Family

ID=26313822

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99925232A Withdrawn EP1143948A3 (fr) 1998-06-08 1999-06-07 Antagoniste des glucocorticoides, specifique du foie, pour le traitement du diabete

Country Status (7)

Country Link
EP (1) EP1143948A3 (fr)
JP (1) JP2002527355A (fr)
KR (1) KR20010052431A (fr)
AU (1) AU751569B2 (fr)
CA (1) CA2334116A1 (fr)
IL (1) IL139865A0 (fr)
WO (1) WO1999063976A2 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9816935D0 (en) * 1998-08-05 1998-09-30 Karobio Ab Novel glucocortoid and thyroid receptor ligands for the treatment of metabolic disorders
GB9907048D0 (en) * 1999-03-27 1999-05-19 Karobio Ab Novel glucocorticoid receptor ligands for the treatment of meta bolic disorders
GB9928805D0 (en) * 1999-12-07 2000-02-02 Karobio Ab Compounds active at the Glucocorticoid and Thyroid Hormone Receptors
ATE303369T1 (de) 2000-10-30 2005-09-15 Pfizer Prod Inc Glucocorticoid rezeptor modulatoren
GB0029102D0 (en) 2000-11-29 2001-01-10 Karobio Ab Compounds active at the glucocorticoid receptor
GB0029100D0 (en) * 2000-11-29 2001-01-10 Karobio Ab Compounds active at the glucocorticoid receptor
WO2002049634A2 (fr) * 2000-12-20 2002-06-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Antagonistes du recepteur glucocorticoide dissocies permettant le traitement des effets secondaires lies au glucocorticoide
JP4499357B2 (ja) * 2001-02-14 2010-07-07 カロ・バイオ・アー・ベー 糖質コルチコイド受容体調節剤
US6583180B2 (en) 2001-02-14 2003-06-24 Abbott Laboratories Glucocorticoid receptor modulators
EP1285927A3 (fr) 2001-08-16 2005-06-29 Schering Aktiengesellschaft Utilisation d'antagonistes du récepteur glucocorticoide pour la prévention et traitement des maladies de la fonction reproductive masculine
EP1572126A4 (fr) * 2001-12-21 2006-07-05 Smithkline Beecham Corp Compositions et methodes servant a modifier la production de glucose
AU2003218342B8 (en) 2002-03-26 2008-07-31 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US7186864B2 (en) 2002-05-29 2007-03-06 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US7074806B2 (en) 2002-06-06 2006-07-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US8097606B2 (en) 2003-07-23 2012-01-17 Corcept Therapeutics, Inc. Antiglucocorticoids for the treatment of catatonia
WO2005012961A1 (fr) 2003-07-31 2005-02-10 Soken Chemical & Engineering Co., Ltd. Cristal colloidal fluide et procede de production de masse de particules tridimensionnelles alignees a partir de ce cristal
UY28526A1 (es) 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
US7795272B2 (en) 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
EP1836166B1 (fr) 2004-12-27 2009-06-17 Boehringer Ingelheim Pharmaceuticals Inc. Composes mimetiques glucocorticoides, compositions pharmaceutiques les contenant, et methodes de fabrication et d'utilisation de ceux-ci
EP2102170A2 (fr) 2006-12-06 2009-09-23 Boehringer Ingelheim International GmbH Substances mimétiques de glucocorticoïde, procédés de préparation de celles-ci, compositions pharmaceutiques et utilisations de celles-ci
SI2300472T1 (sl) 2008-06-06 2012-05-31 Boehringer Ingelheim Int Glukokortikoidni mimetiki postopki za njihovo pripravo farmacevtski sestavki in njihove uporabe
US8138189B2 (en) * 2009-03-26 2012-03-20 Hoffman-La Roche Inc. Substituted benzene compounds as modulators of the glucocorticoid receptor
SG178174A1 (en) 2009-07-31 2012-03-29 Cadila Healthcare Ltd Novel compounds as modulators of glucocorticoid receptors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374148A (en) * 1980-10-21 1983-02-15 Pfizer Inc. Carboxylic acid therapeutic agents
US5929058A (en) * 1996-12-24 1999-07-27 Zymogenetics, Inc. Treatment agents and methods for treating type II diabetes and symptoms of type II diabetes

Also Published As

Publication number Publication date
WO1999063976A2 (fr) 1999-12-16
CA2334116A1 (fr) 1999-12-16
EP1143948A2 (fr) 2001-10-17
AU751569B2 (en) 2002-08-22
JP2002527355A (ja) 2002-08-27
AU4160699A (en) 1999-12-30
KR20010052431A (ko) 2001-06-25
WO1999063976A3 (fr) 2001-12-20
IL139865A0 (en) 2002-02-10

Similar Documents

Publication Publication Date Title
EP1143948A3 (fr) Antagoniste des glucocorticoides, specifique du foie, pour le traitement du diabete
AU8693098A (en) Compositions and methods for treating diabetes
AU5497098A (en) Remedies for diabetes
AU2863899A (en) New compounds
AU7582398A (en) Composition for treating skin conditions
AU3901100A (en) Method and composition for waterproofing
AU3077699A (en) Apparatus for performing hippotherapy
AU4562697A (en) Setting composition for well operations
AU1952601A (en) Estrogens for treating als
AU9750398A (en) D-homo-9,10-secocholesta-23-yne-3,25-diol derivatives
AU3170099A (en) Remedies for obesity
AU5651799A (en) Remedies for photochemotherapy
AUPP433398A0 (en) Compounds and processes
AU3344399A (en) Remedies for primary biliary cirrhosis
IL131059A (en) DUAL PURPOSE INPUT ELECTRODE STRUCTURE FOR MIOCs
AU3556199A (en) Improved methods for making hormone heterodimers
HK1024175A1 (en) Plasters for percutaneous absorption
AU2333099A (en) Aryloxyanilides and related compounds
AU4809000A (en) Method and composition for waterproofing
AU3455000A (en) Composition for decomposing protein
AU5891599A (en) Mixer
AU2863799A (en) New compounds
AU6487298A (en) Underwear for men
AU7624000A (en) Wrist-worn radiotelephone arrangement
AU8386098A (en) Orthopedic supports

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20001221

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

XX Miscellaneous (additional remarks)

Free format text: DERZEIT SIND DIE WIPO-PUBLIKATIONSDATEN A3 NICHT VERFUEGBAR.

PUAK Availability of information related to the publication of the international search report

Free format text: ORIGINAL CODE: 0009015

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20030211

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030822